Company:  NAVIDEA BIOPHARMACEUTICAL ... (NAVB)
Form Type:  8-K
Filing Date:  9/12/2012 
CIK:  0000810509 
Address:  425 METRO PLACE NORTH
SUITE 300
 
City, State, Zip:  DUBLIN, Ohio 43017 
Telephone:  (614) 793-7500 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.75  
Change: 
0.02 (1.16%)  
Trade Time: 
04:04 PM EST  
Market Cap: 
$261.98M
Description of Business
Navidea Biopharmaceuticals, Inc., a Delaware corporation, is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents. Our Company�s core mission is to bring the next generation of precision radiopharmaceutical agents to market so doctors and patients can readily access, and benefit from, cutting-edge diagnostic science. For patients and physicians, we aspire to provide innovative diagnostic imaging agents to improve patient care for serious diseases. For our shareholders, we aim to deliver superior growth through our focus on our innovative diagnostics platforms and products and efficient business processes. For our employees, we provide a culture focused on the direct impact our efforts can have on patients and an innovative development environment enabling new breakthrough products.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 8 OTHER EVENTS
      Item 8.01. Other Events.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 99.1
BROKERAGE PARTNERS